Federal Register Notice: FDA is reopening until 5/18, the comment period for the 2/7 public meeting that sought input on issues that the agency should consider if it decides to propose revisions to its regulations on chemistry, manufacturing, and controls (CMC) supplements and other changes to approved marketing applications for human drugs. FDA is reopening the comment period due to continued public interest in this topic. To view this notice, click here.
